Skip to main content
Top
Published in: Rheumatology International 4/2005

01-05-2005 | Original Article

Does hyaluronan affect inflammatory cytokines in knee osteoarthritis?

Authors: Melek Sezgin, Alev Çevikol Demirel, Cevriye Karaca, Özgür Ortancıl, Gül Bahar Ülkar, A. Kanık, Aytül Çakçı

Published in: Rheumatology International | Issue 4/2005

Login to get access

Abstract

Our aim was to investigate the effects of hyaluronan on inflammatory cytokines in the synovial fluid of patients with knee osteoarthritis. The study was single blind, placebo-controlled, and randomized. We administered hyaluronan to 22 patients in the study group and placebo to 19 in the control group. Enzyme-linked immunosorbent assay was used to determine the levels of cytokines. Both HA and placebo caused a significant decrease in interleukin (IL)-6 levels (P=0.0001 and P=0.04, respectively). But it was more significant in the study group. However, IL-8 and tumor necrosis factor alpha (TNF-α) levels did not change in either group (P>0.05). The amount of effusion decreased significantly in the study group (P=0.001) but not in the control group (P=0.133). It can be concluded that hyaluronan considerably decreased IL-6 levels, which correlated with clinical improvement, but had no effect on IL-8 and TNF-α levels in synovial fluid. However, larger studies with longer follow-up periods are needed to explain the effect of hyaluronan on cytokines.
Literature
1.
go back to reference Mankin HJ (1993) Pathogenesis of osteoarthritis. In: Ruddy S, Harris ED, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 1374–1384 Mankin HJ (1993) Pathogenesis of osteoarthritis. In: Ruddy S, Harris ED, Sledge CB (eds) Textbook of rheumatology. Saunders, Philadelphia, pp 1374–1384
2.
go back to reference Group for the Respect of Ethics and Excellence in Science, Osteoarthritis Section (1996) Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 55:552–557PubMed Group for the Respect of Ethics and Excellence in Science, Osteoarthritis Section (1996) Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 55:552–557PubMed
3.
go back to reference Smith MM, Ghosh P (1987) The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 7:113–122CrossRefPubMed Smith MM, Ghosh P (1987) The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 7:113–122CrossRefPubMed
4.
go back to reference Namiki O, Toyoshima H, Morisaki N (1982) Therapeutic effect of intraarticular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol 20:501–507PubMed Namiki O, Toyoshima H, Morisaki N (1982) Therapeutic effect of intraarticular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol 20:501–507PubMed
5.
go back to reference Frizzero L, Govoni E, Bacchini P (1998) Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheum 16:441–449PubMed Frizzero L, Govoni E, Bacchini P (1998) Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheum 16:441–449PubMed
6.
go back to reference Tobetto K, Yasui T, Ando T (1992) Inhibitory effect of hyaluronan on arachidonic acid release from labelled human synovial fibroblasts. Jpn J Pharmacol 60:79–84PubMed Tobetto K, Yasui T, Ando T (1992) Inhibitory effect of hyaluronan on arachidonic acid release from labelled human synovial fibroblasts. Jpn J Pharmacol 60:79–84PubMed
7.
go back to reference Punzi L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S (1989) The influence of intraarticular hyaluronic acid on PG E2 and CAMP of synovial fluid. Clin Exp Rheum 7:247–250 Punzi L, Schiavon F, Cavasin F, Ramonda R, Gambari PF, Todesco S (1989) The influence of intraarticular hyaluronic acid on PG E2 and CAMP of synovial fluid. Clin Exp Rheum 7:247–250
8.
go back to reference Corrado EM, Peluso G, Gigliotti S, De Durante C, Palmieri D (1995) The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 15:47–56 Corrado EM, Peluso G, Gigliotti S, De Durante C, Palmieri D (1995) The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 15:47–56
9.
go back to reference Presti D, Scott JE (1994) Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH) radicals is dependent on hyaluronan molecular mass. Cell Biochem Function 12:281–288 Presti D, Scott JE (1994) Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH) radicals is dependent on hyaluronan molecular mass. Cell Biochem Function 12:281–288
10.
go back to reference Ghosh P (1994) The role of hyaluronic acid in health and disease: interactions with cells, cartilage and components of the synovial fluid. Clin Exp Rheumatol 12:75–82PubMed Ghosh P (1994) The role of hyaluronic acid in health and disease: interactions with cells, cartilage and components of the synovial fluid. Clin Exp Rheumatol 12:75–82PubMed
11.
go back to reference Westacott C, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25:254–272PubMed Westacott C, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25:254–272PubMed
12.
go back to reference Malfait AM, Verbruggen G, Veys EM, Lambert J, De Ridder L, Cornelissen M (1994) Comparative and combined effects of IL-6, IL-1 beta and TNF alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheum 21:314–320PubMed Malfait AM, Verbruggen G, Veys EM, Lambert J, De Ridder L, Cornelissen M (1994) Comparative and combined effects of IL-6, IL-1 beta and TNF alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheum 21:314–320PubMed
13.
go back to reference Bertazzolo N, Punzi L, Stefani MP (1994) Interrelationships between IL-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions Suppl 41:90–92 Bertazzolo N, Punzi L, Stefani MP (1994) Interrelationships between IL-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions Suppl 41:90–92
14.
go back to reference Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M (2002) Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 40:68–71CrossRefPubMed Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M (2002) Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 40:68–71CrossRefPubMed
15.
go back to reference Goldring MB (1999) The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40:1–11PubMed Goldring MB (1999) The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40:1–11PubMed
16.
go back to reference Kaneko S, Satoh T, Chiba J, Ju C, Inoue K (2000) IL-6 and IL-8 levels in serum and synovial fluid of patients with osteoarthritis. Cyt Cell Mol Ther 6:71–79CrossRef Kaneko S, Satoh T, Chiba J, Ju C, Inoue K (2000) IL-6 and IL-8 levels in serum and synovial fluid of patients with osteoarthritis. Cyt Cell Mol Ther 6:71–79CrossRef
17.
go back to reference Bragantini A, Cassini M, De Bestlani G, Perbellini A (1987) Controlled single-blind trial of intraarticularly injected hyaluronic acid in osteoarthritis of the knee. Clin Trial J 24:333–340 Bragantini A, Cassini M, De Bestlani G, Perbellini A (1987) Controlled single-blind trial of intraarticularly injected hyaluronic acid in osteoarthritis of the knee. Clin Trial J 24:333–340
18.
go back to reference Grecomoro G, Piccione F (1992) Therapeutic synergism between HA and dexamethasone in intraarticular HA in treatment of the osteoarthritis of the knee. A preliminary open study. Cur Med Res Opin 13:49–55 Grecomoro G, Piccione F (1992) Therapeutic synergism between HA and dexamethasone in intraarticular HA in treatment of the osteoarthritis of the knee. A preliminary open study. Cur Med Res Opin 13:49–55
19.
go back to reference Petrella RJ, Di Silvestro MD, Hildebrand C (2002) Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 162:292–298CrossRefPubMed Petrella RJ, Di Silvestro MD, Hildebrand C (2002) Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 162:292–298CrossRefPubMed
20.
go back to reference Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR (2001) Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. Clin Orthop 385:130–143PubMed Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR (2001) Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. Clin Orthop 385:130–143PubMed
21.
go back to reference Isdale AH, Hordon LD, Bird HA, Wright V (1991) Intraarticular hyaluronate (Healon): a dose ranging study in rheumatoid arthritis and osteoarthritis. J Drug Dev 4:93–99 Isdale AH, Hordon LD, Bird HA, Wright V (1991) Intraarticular hyaluronate (Healon): a dose ranging study in rheumatoid arthritis and osteoarthritis. J Drug Dev 4:93–99
22.
go back to reference Abatangelo G, O’Regan M (1995) Hyaluronan: biological role and function in articular joints. Eur J Rheum Inflamm 15:9–16 Abatangelo G, O’Regan M (1995) Hyaluronan: biological role and function in articular joints. Eur J Rheum Inflamm 15:9–16
23.
go back to reference Tamir E, Robinson D, Koren R, Agar G, Halperin N (2001) Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double-blind, placebo-controlled study. Clin Exp Rheumatol 19:265–270PubMed Tamir E, Robinson D, Koren R, Agar G, Halperin N (2001) Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double-blind, placebo-controlled study. Clin Exp Rheumatol 19:265–270PubMed
24.
go back to reference Dixon AJ, Jacoby RK, Berry H, Hamilton EBD (1988) Clinical trial of intraarticular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Cur Med Res Opin 11:205–213 Dixon AJ, Jacoby RK, Berry H, Hamilton EBD (1988) Clinical trial of intraarticular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Cur Med Res Opin 11:205–213
25.
go back to reference Dougados M, Listrat V, Amor B (1993) High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a one year placebo controlled trial. Osteoart Cartil 1:97–103 Dougados M, Listrat V, Amor B (1993) High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a one year placebo controlled trial. Osteoart Cartil 1:97–103
26.
go back to reference Miltner O, Schneider U, Siebert CH, Niedhart C, Niethard FU (2002) Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis—a prospective clinical trial. Osteoart Cartil 10:680–686CrossRef Miltner O, Schneider U, Siebert CH, Niedhart C, Niethard FU (2002) Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis—a prospective clinical trial. Osteoart Cartil 10:680–686CrossRef
27.
go back to reference Carrabba M, Angelini M, Re KA, Torchiana EM, Perpellini (1995) The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15:25–31 Carrabba M, Angelini M, Re KA, Torchiana EM, Perpellini (1995) The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15:25–31
28.
go back to reference Kolarz G, Kotz R, Bröll H (1995) Hyaluronic acid in the treatment of osteoarthritis of the knee joint. Eur J Rheumatol Inflamm 15:39–45 Kolarz G, Kotz R, Bröll H (1995) Hyaluronic acid in the treatment of osteoarthritis of the knee joint. Eur J Rheumatol Inflamm 15:39–45
29.
go back to reference Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicenter trial. Ann Rheumatol Dis 55:424–431 Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicenter trial. Ann Rheumatol Dis 55:424–431
30.
go back to reference Goorman SD, WatanabeTK, Miller EH, Perry C (2000) Functional outcome in knee osteoarthritis after treatment with Hylan GF-20: a prospective study. Arch Phys Med Rehabil 81:479–483CrossRefPubMed Goorman SD, WatanabeTK, Miller EH, Perry C (2000) Functional outcome in knee osteoarthritis after treatment with Hylan GF-20: a prospective study. Arch Phys Med Rehabil 81:479–483CrossRefPubMed
Metadata
Title
Does hyaluronan affect inflammatory cytokines in knee osteoarthritis?
Authors
Melek Sezgin
Alev Çevikol Demirel
Cevriye Karaca
Özgür Ortancıl
Gül Bahar Ülkar
A. Kanık
Aytül Çakçı
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0428-7

Other articles of this Issue 4/2005

Rheumatology International 4/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.